No Additional Information
Rosulip contains Rosuvastatin as the active ingredient which is a selective and competitive inhibitor of HMG-CoA reductase , the rate limiting enzyme in cholesterol synthesis. It increases the number of hepatic LDL receptors on the cell surface ,enhancing uptake and catabolism of LDL. It also decreases apolipoprotein B, triglycerides and increases HDL.
Hyperlipedemia, primary hypercholesterolaemia (heterozygous Familial hypocholesterolaemia), mixed dyslipidaemia, homozygous familial hypercholesterolaemia, stroke prevention.
Direction to Use
Common Side Effects are Headache, Stomach pain, Constipation, Feeling sick, Muscle pain, Weakness, Dizziness, Increased glucose level in blood.